5 Biotechnology companies in New York.
By the Numbers
Proxima
New York
Proxima Bio develops programmable medicines that modulate protein interactions to address disease processes.
Kingdom
Brooklyn
Kingdom develops Superculture ingredients by engineering microbial communities for consumer product manufacturers, building a platform to aggregate, characterize, and assemble natural microbes into scalable solutions. Backed by Y Combinator
Output Biosciences
Output Biosciences pioneers Biologically-Aware Generative AI and Large Biological Models to predict, understand, and program living systems across scales, enabling new medicines and diagnostics. Founded by Adi Mashiach, MD, and Mirella Mash
Serinus Biosciences
Serinus Biosciences is a seed-stage TechBio using a knowledge-primed AI engine to model cancer molecule function in tumor cells. Backed by Y Combinator and Illumina Ventures, its lead program targets a first-in-class PPI with a $20B US mark
Seelos Therapeutics
New York-based · biotechnology.
